Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma.
Chiba Y, Kinoshita M, Okita Y, Tsuboi A, Isohashi K, Kagawa N, Fujimoto Y, Oji Y, Oka Y, Shimosegawa E, Morita S, Hatazawa J, Sugiyama H, Hashimoto N, Yoshimine T.
Chiba Y, et al. Among authors: hatazawa j.
J Neurosurg. 2012 Apr;116(4):835-42. doi: 10.3171/2011.12.JNS111255. Epub 2012 Jan 13.
J Neurosurg. 2012.
PMID: 22242671
Clinical Trial.